Xerostomia one of the Sjögren’s Syndrome Symptoms PDF Print E-mail
Wednesday, 09 June 2010 09:25
“The American Health Institute spent $8 million for a research diagnosis of Sjögren syndrome in several countries as an important disease with high impact on society,” he told The Capital Dr. Ricardo Bazet, ophthalmologist, director of Rosario Self-Help Association for Sjögren syndrome.

One of its main characteristics is the difficulty of arriving at a diagnosis by the multiplicity of symptoms that occurs. This makes the number of fuzzy diagnoses that prevent proper treatment of the disease. “Patients with borderline diagnoses are offered the opportunity to be studies in the German Hospital in Buenos Aires, but not treatment, which should continue in the city of origin,” says Bazet. “The symptoms are not all together,” says the doctor. May occur in different organs by which each specialist is usually just look what it is and not the whole problem. “

Patients who join the study was carried out laboratory tests with blood collection, study eye, Schirmer test, BUT and ocular staining test (fluorescein and lissamine), total and parotid saliva, rheumatologic clinical examination and biopsy of the salivary gland lower. The results of the studies will travel to the U.S. where will supervise each case and classify the data. Finally, the patient returns to information processing will continue with regular doctor.

“The doctors evaluate patients who travel to Buenos Aires for the test. We think it will be two per month, “says the director of the association Rosario, who acknowledges the existence of many patients with misdiagnoses. “The fact that each case is evaluated by the best band in the world Sjögren study determined to be classified the extent of disease (mild, moderate or severe) and that treatment is appropriate to the disease,” adds Bazet.

Treatment should be supervised by a rheumatologist who Bazet as recommended, “must work near an ophthalmologist, pathologist, biochemist and a dermatologist and gynecologist. It seeks to relieve symptoms for a better quality of life, ranging from how to eat, what glasses to use, how to bathe and hydrate the skin, among other guidelines. “

Sjogren’s is an autoimmune disease that causes widespread disruption of the functioning of all the glands of external secretion. The sensation of dry mouth with dry eye are one of the most common. This occurs by decreasing the amount of saliva (hiposalia) or total lack thereof (xerostomia). In most cases occur in this way and a few percent is associated with other autoimmune diseases such as lupus, Scleroderma and psoriasis.

Source: University Five

 
More articles :

» Active Biotech Presents Data regarding the 57-57 Project at EULAR

Active Biotech (NASDAQ OMX Nordic: ACTI) has presented data from an exploratory clinical trial in Systemic Lupus Erythematosus (SLE) patients at the Annual European Congress of Rheumatology EULAR 2011, an international event for specialists in the...

» Calcinosis

Background:The Foundation has recently received some feedback from some members of the public asking for more information regarding the condition known as Calcinosis. As part of our efforts we sought to provide a brief, yet informative insight into...

» Amira Pharmaceuticals Announces Completion of Phase 1 Clinical Study for AM152

Amira Pharmaceuticals, Inc. announced today initial positive data from a Phase 1 clinical study of AM152, the Company's oral selective antagonist of the LPA1 receptor.  Completion of this study positions Amira to initiate a Phase 2a study in...

» Neutrophil Elastase Regulator Needed in Systemic Sclerosis

, which promotes and fibrosis, is suspected of playing a role in (SSc). Theresa C. Barnes, MD, from University of Liverpool, Aintree University Hospital, United Kingdom, and colleagues  of Rheumatology that the problem may not be too...

» arGentis Issued Key Patent Related to Treating Fibrosing Diseases by Induction of Immune Tolerance

arGentis Pharmaceuticals, LLC today announced the issuance of United States patent 7,718,765, entitled “Methods for Treating Fibrosing Diseases by Induction of Immune Tolerance." The issued patent, based on the seminal research of Arnold E....

» Lower Extremity Ulcers in Systemic Sclerosis: Features and Response to Therapy

Victoria K. Shanmugam, MBBS, MRCP; Patricia Price, PhD; Christopher E. Attinger, MD; Virginia D. Steen, MD Non-digital lower extremity ulcers are a difficult to treat complication of scleroderma that is often refractory to therapy. They are a...